Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
The Journal of Headache and Pain
Published in: The Journal of Headache and Pain 1/2015

Open Access 01-12-2016 | Research article

Field testing of the ICHD-3β and expert opinion criteria for chronic migraine

Authors: Huahua Jiang, Yong Deng, Yixin Zhang, Jieli Jin, Xueying Kong, Qiuwen Zhu, Kuiyun Wang, Jiying Zhou

Published in: The Journal of Headache and Pain | Issue 1/2015

Login to get access

Abstract

Background

Chronic headache (CrH) occurs commonly in the population, and chronic migraine (CM) accounts for much of the CrH. Diagnostic criteria for CM remain controversial, and this could lead to undertreatment of CM. The purpose of this study was to analyze the clinical profiles of CM and to field test the International Classification of Headache Disorders-3β criteria (ICHD-3β) and Expert Opinion criteria (EO) for CM application.

Methods

We retrospectively reviewed the medical records of CrH patients in our headache clinic during the period. Eligible patients were selected from CrH population based on Silberstein and Lipton criteria (S-L) for CM, and meanwhile fulfilled with migraine days at least 8 days/month. Then we evaluated the characteristics of clinic profiles and outcomes between patients diagnosed CM using ICHD-3β and EO criteria. Field tested the CM criteria Of ICHD-3β and EO.

Results

In a total of 710 CrH patients , 261 (36.8 %) were recruited with CM based on both S-L criteria and fulfilled at least 8 migraine days/month. Be understandable, all the 261 patients met the EO criteria, and only 185 (70.9 %) met ICHD-3β for CM. For the 76 patients who met EO but not ICHD-3β, 70 had atypical migraine attacks (probable migraine, PM), and another 6 had typical migraine attacks but less than a total history of 5 attacks. Although 173 (66.3 %) were concurrent with medication overuse, just one patient overused triptans and none used ergot agents. Clinical features were not significantly different between the ICHD-3β and EO criteria groups (P > 0.05), and neither were outcomes of prophylaxis (P = 0.966). Total migraine prophylaxis effectiveness was 73 %.

Conclusion

Migraine-specific analgesics are rarely used in China, permitting patients with PM to avail themselves of “migraine days” is a reasonable accommodation for this difficult condition. In our hands, use of the new EO criteria for diagnosis of CM increases the sensitivity and maintains the specificity of decision making, and therefore should be adopted in CM management practice.
Literature
1.
Zwart JA, Dyb G, Hagen K, Svebak S, Holmen J (2003) Analgesic use: A predictor of chronic pain and medication overuse headache The Head–HUNT Study. Neurology 61(2):160–164CrossRefPubMed
2.
Sancisi E, Cevoli S, Vignatelli L, Nicodemo M, Pierangeli G, Zanigni S, Montagna P (2010) Increased prevalence of sleep disorders in chronic headache: a case-control study. Headache 50(9):1464–1472CrossRefPubMed
3.
Pascual J, Colás R, Castillo J (2001) Epidemiology of chronic daily headache. Curr Pain Headache Rep 5(6):529–536CrossRefPubMed
4.
Sanin LC, Mathew NT, Bellmeyer LR, Ali S (1994) The International Headache Society (IHS) headache classification as applied to a headache clinic population. Cephalalgia 14(6):443–446CrossRefPubMed
5.
Huang Q, Li W, Li N, Wang J, Tan G, Chen L, Zhou J (2013) Elevated blood pressure and analgesic overuse in chronic daily headache: an outpatient clinic-based study from China. J Headache Pain 14(1):1CrossRef
6.
Silberstein SD, Lipton RB, Sliwinski M (1996) Classification of daily and near-daily headaches field trial of revised IHS criteria. Neurology 47(4):871–875CrossRefPubMed
7.
Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders: 2nd edition. Cephalalgia 24 Suppl 1:9–160
8.
Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Nappi G (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26(6):742–746CrossRefPubMed
9.
Headache Classification Committee of the International Headache Society (IHS (2013) The international classification of headache disorders, (beta version). Cephalalgia 33(9):629–808CrossRef
10.
Silberstein SD, Lipton RB, Dodick DW (2014) Operational diagnostic criteria for chronic migraine: expert opinion. Headache 54(7):1258–1266CrossRefPubMed
11.
Wang Y, Zhou J, Fan X, Li X, Ran L, Tan G, Liu B (2011) Classification and clinical features of headache patients: an outpatient clinic study from China. J Headache Pain 12(5):561–567CrossRefPubMedPubMedCentral
12.
Zeeberg P, Olesen J, Jensen R (2009) Medication overuse headache and chronic migraine in a specialized headache centre: field-testing proposed new appendix criteria. Cephalalgia 29(2):214–220CrossRefPubMed
13.
Schwedt (2014) Chronic migraine. BMJ 348:g1416
14.
Li N, Wang J, Huang Q, Tan G, Chen L, Zhou J (2012) Clinical features of new daily persistent headache in a tertiary outpatient population. Headache 52(10):1546–1552CrossRef
15.
Silberstein SD, US Headache Consortium (2000) Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 55(6):754–762CrossRefPubMed
16.
Pascual J, El Berdei Y, Gómez-Sánchez JC (2007) How many migraine patients need prolonged (>1 year) preventive treatment? Experience with topiramate. J Headache Pain 8(2):90–93CrossRefPubMedPubMedCentral
17.
Cevoli S, D’Amico D, Martelletti P, Valguarnera F, Del Bene E, De Simone R, Bussone G (2009) Underdiagnosis and undertreatment of migraine in Italy: a survey of patients attending for the first time 10 headache centres. Cephalalgia 29(12):1285–1293CrossRefPubMed
18.
Natoli JL, Manack A, Dean B, Butler Q, Turkel CC, Stovner L, Lipton RB (2010) Global prevalence of chronic migraine: a systematic review. Cephalalgia 30(5):599–609PubMed
19.
Buse DC, Manack AN, Fanning KM, Serrano D, Reed ML, Turkel CC, Lipton RB (2012) Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache 52(10):1456–1470CrossRefPubMed
20.
Zhang Y, Kong Q, Chen J, Li L, Wang D, Zhou J (2016) International Classification of Headache Disorders 3rd edition beta-based field testing of vestibular migraine in China: Demographic, clinical characteristics, audiometric findings and diagnosis statues. Cephalalgia 36(3):240–248CrossRefPubMed
21.
Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB (2007) The International Classification of Headache Disorders revised criteria for chronic migraine—field testing in a headache specialty clinic. Cephalalgia 27(3):230–234CrossRefPubMed
22.
Shand B, Goicochea MT, Valenzuela R, Fadic R, Jensen R, Tassorelli C, Nappi G (2015) Clinical and demographical characteristics of patients with medication overuse headache in Argentina and Chile: analysis of the Latin American Section of COMOESTAS Project. J Headache Pain 16(1):1CrossRef
23.
Dong Z, Chen X, Steiner TJ, Hou L, Di H, He M, Yu S (2015) Medication-overuse headache in China: Clinical profile, and an evaluation of the ICHD-3 beta diagnostic criteria. Cephalalgia 35(8):644–651CrossRefPubMed
24.
Yalın OÖ, Uluduz D, Özge A, Sungur MA, Selekler M, Siva A (2016) Phenotypic features of chronic migraine. J Headache Pain 17(1):1
25.
Lipton RB, Silberstein SD (2015) Episodic and chronic migraine headache: breaking down barriers to optimal treatment and prevention. Headache 55(S2):103–122CrossRefPubMed
26.
Ferrari A, Leone S, Vergoni AV, Bertolini A, Sances G, Coccia CPR, Sternieri E (2007) Similarities and differences between chronic migraine and episodic migraine. Headache 47(1):65–72CrossRefPubMed
27.
Katsarava Z, Schneeweiss S, Kurth T, Kroener U, Fritsche G, Eikermann A, Limmroth V (2004) Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 62(5):788–790CrossRefPubMed
28.
Cho SJ, Song TJ, Chu MK (2016) Outcome of Chronic Daily Headache or Chronic Migraine. Curr Pain Headache Rep 20(1):1–10CrossRef
29.
Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB (2008) Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population‐based study. Headache 48(8):1157–1168CrossRefPubMed
30.
Metadata
Title
Field testing of the ICHD-3β and expert opinion criteria for chronic migraine
Authors
Huahua Jiang
Yong Deng
Yixin Zhang
Jieli Jin
Xueying Kong
Qiuwen Zhu
Kuiyun Wang
Jiying Zhou
Publication date
01-12-2016
Publisher
Springer Milan
Published in
The Journal of Headache and Pain / Issue 1/2015
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI
https://doi.org/10.1186/s10194-016-0678-x

Other articles of this Issue 1/2015

The Journal of Headache and Pain 1/2015 Go to the issue

Research article

Case-control study of GRIA1 and GRIA3 gene variants in migraine

Research article

Right fronto-insular white matter tracts link cognitive reserve and pain in migraine patients

Short report

KYNA analogue SZR72 modifies CFA-induced dural inflammation- regarding expression of pERK1/2 and IL-1β in the rat trigeminal ganglion

Short report

Caffeine discontinuation improves acute migraine treatment: a prospective clinic-based study

Research article

Valproate ameliorates nitroglycerin-induced migraine in trigeminal nucleus caudalis in rats through inhibition of NF-кB

Research article

Methylprednisolone blocks interleukin 1 beta induced calcitonin gene related peptide release in trigeminal ganglia cells